PEOPLE - DCA Design Consultants (UK) makes appointment:
This article was originally published in Clinica
Robert Woolston has been appointed director of medical and scientific product design at DCA Design Consultants in the UK. Mr Woolston, formerly managing senior designer at Sams Design, also in the UK, specialises in design for high volume plastics device manufacture, which includes drug delivery devices such as injectors and inhalers, as well as diagnostic products and technical packaging.
You may also be interested in...
Interview: recently appointed CEO Richard Francis will apply his background in big pharma and biotech to building the UK start-up Purespring Therapeutics with a focus on using gene therapy technology to target renal diseases.
Sandoz Canada has become the first manufacturer to launch generic versions of posaconazole and silodosin in Canada. The company launched the generic version of Allergan’s Rapaflo (silodosin) after a Canadian court ruled that Sandoz did not infringe a key formulation patent.
US healthcare insurance provider Health Net failed to respect Amarin’s patent rights in the way it distributed Hikma’s generic version of Vascepa (icosapent ethyl), the originator contends in an expanded induced infringement suit.